ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Pulmonary Disease

Top Pulmonary Disease Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WAYNE DAVIS MD

Pulmonary Disease

5,069

$279K

157
129 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 61%

$55
Average prescription price

Avg: $141

JOEL TAUBIN M.D.

Pulmonary Disease

2,705

$222K

232
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 61%

$82
Average prescription price

Avg: $141

JOHN YERG M.D.

Pulmonary Disease

1,902

$197K

145
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 61%

$104
Average prescription price

Avg: $141

OCTAVIUS POLK M.D.

Pulmonary Disease

1,850

$188K

153
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 61%

$102
Average prescription price

Avg: $141

LESLIE KINGSLOW MD

Pulmonary Disease

1,680

$439K

124
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 61%

$261
Average prescription price

Avg: $141

LUIS RUIZ M.D.

Pulmonary Disease

1,168

$263K

238
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 61%

$225
Average prescription price

Avg: $141

STEVEN LERNER M.D.

Pulmonary Disease

1,057

$125K

99
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 61%

$118
Average prescription price

Avg: $141

DAVID GROSS M.D.

Pulmonary Disease

978

$329K

146
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 61%

$337
Average prescription price

Avg: $141

EARL ARMSTRONG MD

Pulmonary Disease

948

$120K

97
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 61%

$127
Average prescription price

Avg: $141

BRIAN TURRISI M.D.

Pulmonary Disease

800

$188K

87
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 61%

$235
Average prescription price

Avg: $141

JULIAN CRAIG MD

Pulmonary Disease

596

$88K

73
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

80%
prescriptions for brand name drugs

Avg: 61%

$148
Average prescription price

Avg: $141

ANNE O'DONNELL

Pulmonary Disease

514

$96.6K

69
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 61%

$188
Average prescription price

Avg: $141

PETER LEVIT MD

Pulmonary Disease

434

$197K

37
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 61%

$453
Average prescription price

Avg: $141

MORGAN DELANEY MD

Pulmonary Disease

357

$64.1K

44
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 61%

$180
Average prescription price

Avg: $141

GENE COLICE MD

Pulmonary Disease

349

$55.7K

42
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 61%

$160
Average prescription price

Avg: $141

ERIC ANDERSON

Pulmonary Disease

234

$37.1K

39
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 61%

$159
Average prescription price

Avg: $141

CHARLES READ

Pulmonary Disease

206

$47.4K

39
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

84%
prescriptions for brand name drugs

Avg: 61%

$230
Average prescription price

Avg: $141

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank